Seokhan Song
Family Medicine · Vinton, IANPI 1194163170
Payments from drug & device makers
Across 148 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$275
- Astellas Pharma US Inc$268
- Pfizer$258
- Novo Nordisk$217
- AbbVie$177
- Lilly USA, LLC$164
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,59693%
- Education$2097%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $275 |
| Astellas Pharma US Inc | 7 | $268 |
| Pfizer | 15 | $258 |
| Novo Nordisk | 12 | $217 |
| AbbVie(2 entities) | 9 | $177 |
| Lilly USA, LLC | 11 | $164 |
| Boehringer Ingelheim | 8 | $155 |
| Sumitomo Pharma America, Inc. | 5 | $131 |
| Amgen | 7 | $108 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $95 |
| Novartis | 5 | $92 |
| Merck | 4 | $85 |
| Phathom Pharmaceuticals, Inc. | 3 | $66 |
| GSK | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Sanofi Pasteur Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Inspire Medical Systems, Inc. | 2 | $48 |
| Abbott | 2 | $44 |
| Dexcom, Inc. | 2 | $43 |
| Baxter Healthcare | 2 | $40 |
| Amarin Pharma, Inc. | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Organogenesis Inc. | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $20 |
| Bayer | 1 | $19 |
| Gilead | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Harmony Biosciences LLC | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$2,805 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 60 | $75,330 |
| JardianceEmpagliflozin | 34 | $28,337 |
| RybelsusSemaglutide | 15 | $19,808 |
| XareltoRivaroxaban | 39 | $18,757 |
| FarxigaDapagliflozin Propanediol | 30 | $16,981 |
| EliquisApixaban | 29 | $15,836 |
| MounjaroTirzepatide | 14 | $14,769 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $13,035 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $10,744 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $7,813 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $4,833 |
| Serevent DiskusSalmeterol Xinafoate | 12 | $4,821 |
| Arnuity ElliptaFluticasone Furoate | 15 | $3,369 |
| Gabapentin | 162 | $2,831 |
| Atorvastatin Calcium | 224 | $1,851 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $217 | $95,13875 claims |
| Boehringer IngelheimJardiance | $155 | $28,33734 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $65 | $24,21745 claims |
| AstraZenecaFarxiga, Symbicort | $275 | $21,81444 claims |
| PfizerEliquis | $258 | $15,83629 claims |
| Lilly USA, LLCMounjaro | $164 | $14,76914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Vinton
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
- Stephen HarrisonClinton$249K
- Sharon SteenBelle Plaine$241K
- Carlos Alarcon SchroderJohnston$237K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.